Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CYBN is expected to report earnings to rise 68.71% to -2 cents per share on November 13
Q3'24
Est.
$-0.02
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.03
Q4'23
Missed
by $0.03
Q3'23
Est.
$-0.03
The last earnings report on August 08 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 185.13K shares outstanding, the current market capitalization sits at 130.92M.